Avoidance of large or high-fat meals can be helpful
Customer Contact: [email protected] The company's terms explicitly state: "Platform Operator operates solely as an intermediary between User and a Seller
The body of evidence across multiple studies in various countries is conclusive that treatment with GLP-1 medications for type 2 diabetes and/or overweight/obesity is strongly associated with an elevated risk of developing NAION
Limitations & Considerations Long-term data are limited
Medical patches are indicated for other issues, like hormone replacement therapy, infertility, smoking cessation, and morebut some medical experts caution that the GLP-1 patches can be misleading
Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: a randomized trial in adults with obesity and prediabetes